Clinical Research & Clinical Trials

Post-Market Surveillance and Phase IV Trials

This session will focus on the role of post-market surveillance and Phase IV trials in ensuring long-term drug safety and efficacy. Topics will include designing and conducting Phase IV studies, monitoring real-world drug use, and managing adverse events. Discussions will explore the use of real-world data and digital tools to enhance post-market surveillance and meet regulatory requirements. Case studies will provide insights into successful Phase IV trials and highlight best practices for maintaining patient safety.